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A 30-year-old Japanese woman with chest pain and nodules in the left upper lung ﬁeld was diagnosed as
having pulmonary tuberculosis by sputum examination. Purpura on her legs had lasted for 3 months and
her platelet count was 1.9  104/mm3 on admission. She was also diagnosed as having immune
thrombocytopenic purpura because of elevation of serum PA-IgG and proliferation of megakaryocytes in
the bone marrow. Anti-tubercular therapy and steroid therapy were concurrently performed, resulted in
recovery of the platelet count. Steroid therapy was gradually tapered off and then withdrawn, thereafter
anti-tubercular therapy was ﬁnished. She has been relapse-free.
Cases of pulmonary tuberculosis accompanied with immune thrombocytopenic purpura are rare. The
pathogenesis in the present case was suggested to have occurred through an immunological mechanism.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Pulmonary tuberculosis is often accompanied with hematolog-
ical abnormalities.1,2 Thrombocytopenia has also sometimes
occurred,3 but subsequent to the tuberculosis in most of the cases.
For example, there are cases of patients affected with tuberculosis
under steroid therapy for immune thrombocytopenic purpura or
patients with tuberculosis accompanied thrombocytopenia as
a side effect of anti-tubercular drugs. However, cases of thrombo-
cytopenia secondary to tuberculosis through an immunological
mechanism have been rare.3–5 We report herein on a case of
pulmonary tuberculosis with immune thrombocytopenic purpura.
2. Case report
A 30-year-old woman was suffering from left chest pain. Two
weeks after the onset, she was admitted to our hospital for detailed
examination of abnormal chest shadows. In addition, purpura on
her legs had lasted for 3 months before admission. On physical
examination there were no abnormal ﬁndings except for the leg
purpura. Her chest roentgenogram and computed tomography (CT): þ81 6 6853 3127.
.
rved.scan showed multiple nodules and dissemination in the upper lob
of the left lung (Fig. 1). Some of those nodules had formed cavita-
tions. She was diagnosed as having pulmonary tuberculosis
becauseMycobacterium tuberculosiswas detected in her sputum. In
addition, her platelet count was 1.9  104/mm3 on admission,
serum platelet associated-immunoglobulin G (PA-IgG) was
elevated to 266 ng/106cells (normal range: 5–25) and megakar-
yocytes in the bone marrow had increased to 222/mm3 (normal
range: 50–150). Therefore she was also diagnosed as having
immune thrombocytopenic purpura. However, splenomegaly was
not detected, and IgG antibodies against Helicobacter pylori were
negative.
She was treated with anti-tubercular therapy composed of
isoniazid, rifampicin and ethanbutol, and steroid therapy with
high dose methylpredonisolone for three days was concurrently
performed, resulting in gradual recovery of the platelet count
(Fig. 2). After that, 30 mg of oral predonisolone (PSL) was also
continued, and pyradinamide was added. Three months later, the
platelet count was maintained above 15  104/mm3 and the
tuberculosis lesions had also improved. The steroid was gradually
reduced to 5 mg per two weeks and withdrawn 5 months later,
and the anti-tubercular therapy for 9 months was ﬁnished. She
has been free from relapse of both lung tuberculosis and throm-
bocytopenia for 2 years until now. PA-IgG was within normal
limits after a year.
Fig. 1. Chest X-ray and CT scan on admission and after therapy for tuberculosis. Chest X-ray (left upper) and CT scan (left lower) demonstrate multiple nodules and dissemination in
the left upper lung ﬁeld on admission. Some of those nodules have formed cavitations. The nodules in the left upper lung ﬁeld have almost vanished after a year (right).
M. Mori et al. / Respiratory Medicine CME 3 (2010) 232–234 2333. Discussion
Pulmonary tuberculosis has been reported as sometimes being
accompanied by thrombocytopenia.3 There were some case reports
that patients under steroid therapy for immune thrombocytopenic
purpura have been affected with tuberculosis. In other cases,
thrombocytopenia was induced by hemophagocytic syndrome or
invasion of the bone marrow because of the serious conditions of
tuberculosis.6,7 On the other hand, thrombocytopenia as a side
effect of anti-tubercular drugs has also been reported, with rifam-
picin inducing thrombocytopenia at a relatively high frequency
compared to other drugs.8 Moreover, PA-IgG was positive in some
of the cases.9
However, the cases where the immune mechanism was the
causative factor have been rare. al-Majed et al. reported that in 846
patients with tuberculosis, only 9 were accompanied with immune
thrombocytopenia.3 By reviewing the reported cases, thrombocy-
topenia was resolved in all cases, most of which were treated with
steroid therapy.4,5 In our case, the onset of purpura was 3 months
before the diagnosis of tuberculosis, that was thought to be theFig. 2. The course of the platelet count during the treatment course for tuberculosis
and immune thrombocytopenia.period during which tuberculosis had become worse. Furthermore,
the cessation of the steroid therapy 5 months after diagnosis was
unable to induce the relapse of the thrombocytopenia. The platelet
counts were clearly associated with the activity of lung tubercu-
losis. In addition, PA-IgG levels as the immunological index were
high at the beginning, however, they normalized after a year. Only
40% of patients with idiopathic ITP recovered following treatment
with corticosteroids alone, and many of them needed low dose of
steroids as maintenance.10 For these reasons we attribute throm-
bocytopenia to an immune mechanism associated with tubercu-
losis in our case.
Although the direct cause of immune thrombocytopenia was
not apparent, recently many have reported an association with
H. pylori.11 About 40–60% of patients with ITP obtained remission
with eradication of H. pylori.12 In these cases, the molecular
mimicry between the Cytotoxin-associated antigen A of H. pylori
and platelet membrane has been strongly hypothesized.13 Chronic
viral infections, for example, human immunodeﬁciency virus or
hepatitis C virus, have also been suspected as causes.10 The mech-
anism of immune thrombocytopenia secondary to tuberculosis has
been rarely discussed. However, the possibility of the molecular
mimicry between an unknown tuberculosis-speciﬁc protein and
platelet membrane could be considered.
We treated our patients with corticosteroids at the early stage,
resulting in remission of the platelet count. In most of the previ-
ously reported cases, steroid therapy was performed; however,
some patients were treatedwith large amount of g-globulin instead
of steroids because of the enlarged risk of infection.5 If thrombo-
cytopenia were to be accompanied with little episodes of bleeding,
only anti-tubercular drugs but not steroids could be administered
under a cautious observation of the platelet count.
We experienced a case of lung tuberculosis simultaneously
accompanied with immune thrombocytopenic purpura. This report
illustrates immune thrombocytopenia as a rare manifestation of
tuberculosis.
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